Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 1069
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Ceffectan 25 mg/ml V/DCP/18/0005 Wirtschaftsgenossenschaft deutscher Tierarzte eG, Vācija QJ01DE90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Cefquinome
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Wirtschaftsgenossenschaft deutscher Tierarzte eG, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 280218LI (02-Mar-2018)
Labelling text: [PDF] 280218M (02-Mar-2018)
Summary of product characteristics: [PDF] 280218ZA (02-Mar-2018)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0005-01 1 Stikla flakons, 100 ml -
V/DCP/18/0005-02 6 Stikla flakons, 100 ml -
V/DCP/18/0005-03 12 Stikla flakons, 100 ml -
V/DCP/18/0005-04 1 Stikla flakons, 250 ml -
V/DCP/18/0005-05 6 Stikla flakons, 250 ml -
Vetmedin 2.5 mg - V/NRP/00/1126 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: capsules for oral use
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Klocke Pharma Service GmbH, Vācija
Date of authorisation/renewal: 15-Feb-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 31072019LI (31-Jul-2019)
Labelling text: [PDF] 31072019M (31-Jul-2019)
Summary of product characteristics: [PDF] 31072019ZA (31-Jul-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/00/1126-01 2,5 mg 1 Polietilēna pudelīte, 100 tablete -
Vetmedin 5 mg - V/NRP/09/0003 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: capsules for oral use
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Klocke Pharma Service GmbH, Vācija
Date of authorisation/renewal: 15-Feb-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 31072019LI (31-Jul-2019)
Labelling text: [PDF] 31072019M (31-Jul-2019)
Summary of product characteristics: [PDF] 31072019ZA (31-Jul-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/09/0003-01 5 mg 1 Polietilēna pudele, 100 kapsulas -
Feligen CRP/R - V/NRP/08/1594 Virbac S.A., Francija QI06AD04 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Feline rhinotracheitis virus,Inactivated Rabies virus,Live attenuated feline panleucopenia virus,Live feline calicivirus, strain F9
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 30-May-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1594-01 10 Stikla flakons, 1 deva -
V/NRP/08/1594-02 50 Stikla flakons, 1 deva -
Cevac IBD 2512 L - V/MRP/13/0005 Ceva Sante Animale., Francija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oral suspension
International name (active substance): Avian infectious bursal disease virus Winterfield 2512, G-61 strain
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Apr-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 270417LI (28-Apr-2017)
Labelling text: [PDF] 270417M (28-Apr-2017)
Summary of product characteristics: [PDF] 270417ZA (28-Apr-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0005-01 20 Stikla flakons, 1000 deva -
V/MRP/13/0005-02 20 Stikla flakons, 2500 deva -
V/MRP/13/0005-03 20 Stikla flakons, 5000 deva -
Vetemex 10 mg/ml V/SRP/23/0013 CP-Pharma Handelsgesellschaft GmbH, Vācija QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 28-Mar-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Mar-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Mar-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/23/0013-01 1 Stikla flakons, 10 ml -
V/SRP/23/0013-02 1 Stikla flakons, 20 ml [PDF] [PDF]
V/SRP/23/0013-03 1 Stikla flakons, 25 ml -
V/SRP/23/0013-04 1 Stikla flakons, 50 ml -
Presedine 10 mg/ml V/DCP/23/0017 Alfasan Nederland BV, Nīderlande QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0017-01 10 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/23/0017-02 10 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/23/0017-03 10 mg/ml 1 Stikla flakons, 20 ml -
Spirovet 600000 IU/ml V/MRP/12/0056 Ceva Sante Animale', Francija QJ01FA02 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Spiramycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0056-01 600000 IU/ml 1 Stikla flakons, 50 ml -
V/MRP/12/0056-02 600000 IU/ml 1 Stikla flakons, 100 ml -
V/MRP/12/0056-03 600000 IU/ml 1 Stikla flakons, 250 ml -
V/MRP/12/0056-04 600000 IU/ml 1 Plastmasas pudele, 50 ml -
V/MRP/12/0056-05 600000 IU/ml 1 Plastmasas pudele, 100 ml -
V/MRP/12/0056-06 600000 IU/ml 1 Plastmasas pudele, 250 ml -
Prinocate 40 mg/4 mg - V/DCP/20/0005 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 ferrets; small cats

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0005-01 40/4 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-02 40/4 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-03 40/4 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-04 40/4 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-05 40/4 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-06 40/4 48 Polipropilēna pipete, 0,4 ml -
Prinocate 80 mg/8 mg - V/DCP/20/0006 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0006-01 80/8 mg 1 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-02 80/8 mg 3 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-03 80/8 mg 4 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-04 80/8 mg 6 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-05 80/8 mg 24 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-06 80/8 mg 48 Polipropilēna pipete, 0,8 ml -
Prinocate 40 mg/10 mg - V/DCP/20/0007 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0007-01 40/10 mg 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-02 40/10 mg 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-03 40/10 mg 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-04 40/10 mg 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-05 40/10 mg 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-06 40/10 mg 48 Polipropilēna pipete, 0,4 ml -
Prinocate 100 mg/25 mg - V/DCP/20/0008 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0008-01 100/25 mg 1 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-02 100/25 mg 3 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-03 100/25 mg 4 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-04 100/25 mg 6 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-05 100/25 mg 24 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-06 100/25 mg 48 Polipropilēna pipete, 1 ml -
Prinocate 250 mg/62,5 mg - V/DCP/20/0009 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0009-01 250/62,5 mg 1 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-02 250/62,5 mg 3 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-03 250/62,5 mg 4 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-04 250/62,5 mg 6 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-05 250/62,5 mg 24 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-06 250/62,5 mg 48 Polipropilēna pipete, 2,5 ml -
Prinocate 400 mg/100 mg - V/DCP/20/0010 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0010-01 400/100 mg 1 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-02 400/100 mg 3 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-03 400/100 mg 4 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-04 400/100 mg 6 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-05 400/100 mg 24 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-06 400/100 mg 48 Polipropilēna pipete, 4 ml -
Cepedol Vet 20 mg V/DCP/24/0018 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0018-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Cepedol Vet 50 mg V/DCP/24/0019 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0019-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Mexxam Vet 15 mg/ml V/DCP/23/0001 Alfasan Nederland BV, Nīderlande QM01AC06 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande;Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 23-Jan-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (23-Jan-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0001-01 1 Polietilēna pudelīte, 125 ml -
V/DCP/23/0001-02 1 Polietilēna pudelīte, 336 ml -
Cardisan 1.25 mg V/DCP/22/0050 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0050-01 1,25 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-02 1,25 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-03 1,25 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-04 1,25 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-05 1,25 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 2.5 mg V/DCP/22/0051 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0051-01 2,5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-02 2,5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-03 2,5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-04 2,5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-05 2,5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 5 mg V/DCP/22/0052 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0052-01 5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-02 5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-03 5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-04 5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-05 5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -

3081 record